MedTrace Logo

Stroke Prevention and Rhythm Control Therapy STEEER-AF

NCT04396418 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1732

Last updated 2024-06-20

No results posted yet for this study

Summary

A prospective trial with hospitals/health centres across 6 different European countries, being randomised to either a structured education programme as the intervention or no additional education as the control. To determine whether a comprehensive educational programme for healthcare professionals will increase the rate of appropriate stroke prevention and rhythm control therapy in patients with atrial fibrillation (AF) and adherence to Guidelines.

Conditions

Interventions

BEHAVIORAL

Education

Randomization between two groups at site level. One cluster with education and one without.

Sponsors & Collaborators

Principal Investigators

  • Hein Heidbuchel · Universiteit Antwerpen

  • Dipak Kotecha · University of Birmingham

  • Isabelle van Gelder · University Medical Center Groningen, The Netherlands

  • Serge Boveda · Clinique Pasteur, France

  • Philipp Sommer · Ruhr-Universität Bochum, Germany

  • Giuseppe Boriani · University of Modena & Reggio Emilia

  • Maciej Sterliński · National Institute of Cardiology, Warsaw, Poland

  • Luis Mont · University of Barcelona, Spain

  • Kim Rajappan · University of Oxford, UK

  • Eduard Guasch · University of Barcelona, Spain

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-29
Primary Completion
2024-01-10
Completion
2025-12-30

Countries

  • France
  • Germany
  • Italy
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04396418 on ClinicalTrials.gov